Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Food
Food & Beverages/Dietary Supplements

NSE Products, Inc.: Pharmanex Jungamals Recalled for Undeclared Fish Allergen

Agency Publication Date: November 2, 2021
Share:
Sign in to monitor this recall

Summary

Approximately 470 bottles of Pharmanex Kids Jungamals Dietary Supplement (90 chewable tablets) have been recalled because they contain fish gelatin that was not listed on the product label. The fish gelatin is a component of the Vitamin E used in the tablets. This recall specifically affects white bottles of the supplement distributed directly to consumers across the country. Consumers who have purchased the product and have a fish allergy should not consume it and can return it to the place of purchase for a full refund.

Risk

Consumers with an allergy or severe sensitivity to fish run the risk of a serious or life-threatening allergic reaction if they consume these supplements. The missing label statement fails to warn sensitive individuals that fish gelatin is present in the Vitamin E ingredient.

What You Should Do

  1. Check your white bottle of Pharmanex Kids Jungamals (90 Chewable Tablets) to see if it is part of the recalled batch.
  2. Locate the batch code and expiration date on the packaging: this recall only applies to products with Batch Code CS11711 and an Expiration Date of April 30, 2022.
  3. If you have a fish allergy or sensitivity, stop using the product immediately and do not consume any remaining tablets.
  4. Return the affected product to the place where you purchased it for a full refund.
  5. For further instructions or questions regarding this recall, contact NSE Products, Inc. at 1-888-PHARMANEX.
  6. If you believe you have experienced an allergic reaction or other health issue from this product, contact your healthcare provider immediately.
  7. For additional information, you may contact the FDA Consumer Complaint hotline at 1-888-723-3332.

Your Remedy Options

💰Full Refund

Full refund upon return of the product.

How to: Return to the place of purchase for a full refund or contact the manufacturer for further instructions.

Affected Products

Product: Pharmanex Kids Jungamals, Dietary Supplement (90 Chewable Tablets)
Item Code:
F-0095-2022
Lot Numbers:
CS11711 (Exp April 30, 2022)
Date Ranges: April 30, 2022

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 88804
Status: Resolved
Manufacturer: NSE Products, Inc.
Sold By: NSE Products, Inc.; Direct to consumers
Manufactured In: United States
Units Affected: 470 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.